Cognitive Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: An Online Introduction (July 2023)

July 10, 2023 to August 28, 2023

Registration Deadline: July 27, 2023

Avoidant/Restrictive Food Intake Disorder (ARFID) was recently added to the Feeding and Eating Disorders section of DSM-5 to describe children, adolescents, and adults who do not eat enough food (by variety or volume), typically because of sensory sensitivity, fear of aversive consequences (e.g., choking, vomiting), and/or apparent lack of interest in eating or food. Although there is a robust literature on pediatric feeding disorders in very young children, ARFID itself is so new that there is currently no evidence-based treatment for older children, adolescents, or adults. Thus, our online course will fill an important gap for our colleagues who are already seeing such patients in clinical practice by providing specialized training in a new form of cognitive-behavioral therapy for ARFID (CBT-AR) that we have developed and refined at Massachusetts General Hospital for patients ages 10 through older adults. Early data from our preliminary efficacy studies indicate that, on average, patients who receive CBT-AR incorporate many novel foods into their regular diets, gain significant weight (if underweight), and significantly reduce both ARFID symptom severity and food neophobia. Our 6-week course will cover the assessment of ARFID and determining patient appropriateness of CBT-AR, as well as the implementation of all four stages of this flexible, modular treatment. Material will be drawn from our recently published books (Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Children, Adolescents, and Adults, Cambridge University Press, 2019; and The Picky Eater’s Recovery Book: Overcoming Avoidant/Restrictive Food Intake Disorder, Cambridge University Press, 2021), cases we have seen in our clinical practice, and our ongoing research studies on the neurobiology and treatment of ARFID.

Course materials are available beginning on July 10, 2023 and all online course work must be completed by August 28, 2023.

Pricing

Registration Deadline: July 27, 2023

Physicians and Doctoral-level Professionals: $445.00
Other Professionals: $345.00

Cancellation Policy

Refunds will be issued for cancellation requests made during the first week of the course, but an administrative fee of $25.00 will be deducted from your refund. Cancellation requests made during the second week will receive a credit toward a future offering of the same course. No refunds or credits will be granted after July 27, 2023.

Q&A Schedule

Week Start Date	Date of Q&A	Time of Q&A	Faculty Name
Week 1: 7/10/2023	7/11/2023	9:00-9:30AM EDT	Kendra R. Becker, PhD
Week 2: 7/17/2023	7/19/2023	9:00-9:30AM EDT	Kamryn T. Eddy, PhD
Week 3: 7/24/2023	7/27/2023	2:00-2:30PM EDT	Jennifer J. Thomas, PhD
Week 4: 7/31/2023	8/01/2023	9:00-9:30AM EDT	Kendra R. Becker, PhD
Week 5: 8/07/2023	8/09/2023	9:15-9:45AM EDT	Jennifer J. Thomas, PhD
Week 6: 8/14/2023	8/16/2023	9:00-9:30AM EDT	Kamryn T. Eddy, PhD

Restriction on Use of Materials

This site is operated and maintained by The Massachusetts General Hospital Psychiatry Academy. No material or information from this site may be copied, reproduced, republished, uploaded, posted, transmitted or distributed unless approved in writing by The Psychiatry Academy. Questions concerning the proper use of materials and information in this site should be directed to: mghcme@mgh.harvard.edu. No rights or licenses of any kind of The Psychiatry Academy’s intellectual property are transferred to, granted to, provided to or received by you as a result of using this web site.

Target Audience

This program is intended for health professionals who may encounter patients with ARFID (of all ages) in their clinical practice. In our experience, this includes a wide range of clinicians including psychologists, psychiatrists, social workers, other mental health workers, dietitians, primary care physicians, pediatricians, nurses, nurse practitioners, speech/language pathologists, and occupational therapists.

Learning Objectives

At the end of this program, participants will be able to:

• Discuss how to confer a diagnosis of ARFID based on DSM-5 criteria and describe the assessments (e.g., interviews, self-report questionnaires) that can be used to assess severity.

• Describe the type of patients with ARFID for whom cognitive-behavioral therapy is appropriate.

• Describe the basic structure, goals, and session format of cognitive-behavioral therapy for avoidant/restrictive food intake disorder (CBT-AR).

• Use all four stages of this flexible, modular treatment

• Use Stage 1 of CBT-AR including psychoeducation and early change to volume and/or variety of food.

• Use Stage 2 of CBT-AR including treatment planning and selection of modules to utilize in Stage 3.

• Design a program in Stage 3 to address sensory sensitivity by implementing the 5 steps of learning about new foods and utilizing strategies for moving new foods from tasting to incorporation.

• Design treatment strategies in Stage 3 that will address fear of aversive consequences by developing and working through a fear and avoidance hierarchy.

• Design a program in Stage 3 to address lack of interest in eating or food by increasing exposure to highly preferred foods, enhancing awareness of hunger cues through self-monitoring, and conducting interoceptive exposures.

• Use Stage 4 of CBT-AR including relapse prevention and planning for the future.

• Discuss how to end the therapy on time as planned.

• Describe how to trouble-shoot common clinical challenges in CBT-AR.

Course summary

Available credit:

13.50 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 13.50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
13.50 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 13.50 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
13.50 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 13.50 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 91121
13.50 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
13.50 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 13.50 Continuing Education (CE) credits per presentation for psychologists.

Registration opens:

05/01/2023

Course closes:

06/05/2023

Event starts:

07/10/2023 - 1:00am EDT

Event ends:

08/28/2023 - 11:59pm EDT

Cost:

$445.00

Add to calendar:

Rating:

Participants must complete each week sequentially and while completing all components of each week to receive credit, including:

Activity Overview
Video Lecture
Reading and Resources (required and optional)
Q&A with Faculty
Discussion Board
Case Assessment

Week 1 — Assessment of ARFID and introduction to Cognitive-Behavioral Therapy for ARFID (CBT-AR)

Discuss how to confer a diagnosis of ARFID based on DSM-5 criteria and describe the assessments (e.g., interviews, self-report questionnaires) that can be used to assess severity.
Describe the type of patients with ARFID for whom cognitive-behavioral therapy is appropriate.
Describe the basic structure, goals, and session format of CBT-AR.

Week 2 — CBT-AR Stage 1-2

Implement Stage 1 of CBT-AR including psychoeducation and early change to volume and/or variety of food.
Utilize the therapeutic meal for patients who are underweight.
Implement Stage 2 of CBT-AR including treatment planning and selection of modules to utilize in Stage 3.

Week 3 — CBT-AR Stage 3: Sensory sensitivity

Design a program to address sensory sensitivity by implementing the 5 steps of learning about new foods and utilizing strategies for moving new foods from tasting to incorporation.

Week 4 — CBT-AR Stage 3: Fear of aversive consequences

Design a treatment that will address fear of aversive consequences by developing and working through a fear and avoidance hierarchy.

Week 5 — CBT-AR Stage 3: Lack of interest in eating or food

Design a program to address lack of interest in eating or food by increasing consumption of highly preferred foods, enhancing awareness of hunger cues through self-monitoring, and conducting interoceptive exposures.

Week 6 — CBT-AR Stage 4, CBT-AR Efficacy

Implement Stage 4 of CBT-AR including relapse prevention and planning for the future.
Discuss how to end the therapy on time as planned.
Describe how to trouble-shoot common clinical challenges in CBT-AR.
Describe the preliminary evidence of efficacy for CBT-AR.

Course Director(s)

Kendra Becker, PhD

has a financial relationship (Professional Services) with Cambridge University Press;.

has a financial relationship (Professional Services) with Kendra R Becker Private Practice;.

Kamryn Eddy, MD

has a financial relationship (Professional Services) with Cambridge University Press (author of "Cognitive-Behavioral Therapy for ARFID");.

Jennifer Thomas, PhD

has a financial relationship (Copyright) with Oxford University Press;.

has a financial relationship (Copyright) with Harvard Health Publications/Hazelden;.

has a financial relationship (Professional Services) with Honorarium for travel to conference as member of the Board of Directors;.

has a financial relationship (Copyright) with Cambridge University Press;.

has a financial relationship (Professional Services) with Honorarium from John Wiley & Sons;.

Planner(s)

Jane Pimental, MPH

has no relevant financial relationships to disclose at this time.

David Rubin, MD

has no relevant financial relationships to disclose at this time.

Susan Sprich, Ph.D.

has a financial relationship (Other) with Association for Behavioral and Cognitive Therapies (ABCT);.

has a financial relationship (Other) with Springer;.

has a financial relationship (Other) with Oxford University Press;.

Speaker(s)